药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Natamycin
Fluspirilene
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Fluspirilene.
Natamycin
Prenylamine
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Prenylamine.
Natamycin
Granisetron
The risk or severity of QTc prolongation can be increased when Granisetron is combined with Clarithromycin.
Natamycin
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Dexchlorpheniramine.
Natamycin
Lorcainide
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Lorcainide.
Natamycin
Bunaftine
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Bunaftine.
Natamycin
Nizofenone
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Nizofenone.
Natamycin
Sultopride
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Sultopride.
Natamycin
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Sitafloxacin.
Natamycin
Oxatomide
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Oxatomide.
Natamycin
Abexinostat
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Abexinostat.
Natamycin
Mizolastine
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Mizolastine.
Natamycin
Ricolinostat
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Ricolinostat.
Natamycin
Simendan
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Simendan.
Natamycin
CUDC-101
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with CUDC-101.
Natamycin
Entinostat
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Entinostat.
Natamycin
Mocetinostat
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Mocetinostat.
Natamycin
Amifampridine
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Amifampridine.
Natamycin
Melperone
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Melperone.
Natamycin
Butriptyline
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Butriptyline.